Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Zonisamide-13C6 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco Z0061ML
Description
Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and generalized tonic clonic seizure. Zonisamide is marketed in the US under the trade name Zonegran™.Specifications
67-56-1, 1435934-68-1 | |
UN 1230 - class 3 - PG 2 - Methanol, solution | |
218.18 | |
1 mL |
13C6C2H8N2O3S | |
100 μg/mL in methanol | |
Ampule | |
9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : -20°C
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation